Diarrhea Articles & Analysis

Robert Hancock and Olga Peña—who lost her father to sepsis—may have found a way to diagnose the deadliest syndrome you’ve never heard of. The doctor suspected 70-year-old Augustin Peña had the flu, so he sent him home to rest and drink lots of fluids. But after three days of continuing to suffer, Peña entered the local hospital in Tolima, Colombia. His ...

By Sepset Biosciences Inc.

In celebration of the 2024 Global Handwashing Day (GHD), West Zone concessionaire Maynilad Water Services, Inc. (Maynilad) engaged 600 students and 60 teachers from nine public schools, promoting the importance of proper health and hygiene practices. Maynilad, in partnership with the Department of Education (DepEd) and local governments of Pasay and Quezon City, organized interactive ...

By Maynilad Water Services, Inc.

The environmental and infection control experts at EC2 provide prevention services, inspections and solutions for healthcare facilities battling C. diff threats. Just last week it was reported that an outbreak of C. difficile (C. diff) at a Canadian hospital has already infected 63 patients. The outbreak has caused at least one confirmed death and possibly six others. This latest ...

By Cochrane & Associates, LLC

AnX Robotica Corp receives 510(k) clearance from FDA to market its IntraMarX™ Radiopaque Markers Plano, TX March 31st, 2020 – AnX Robotica Corp (AnX) today announced that it has received FDA 510(k) clearance to market its IntraMarX™ Radiopaque Markers (ROM). Radiopaque markers are used to measure colon transit time and they are the most basic and primary tool in evaluating ...

By AnX Robotica

A mother of four from Chadler, Arizona is waging a war against dirty playgrounds at fast-food restaurants. Dr. Erin Carr-Jordan was horrified when she discovered that the local McDonald’s jungle gym where her children played was filthy. The staff did not clean it—even after repeated complaints—so she decided to take matters into her own hands and take samples of the grime ...

By EMSL Analytical, Inc.

Clostridium difficile, also known as C. diff, CDI and C. difficile, is a bacterium that may develop due to the prolonged use of antibiotics during healthcare treatment. C. diff infections cause diarrhea and more serious intestinal conditions such as colitis. It is a major culprit for healthcare associated infections (HAIs) and has been increasingly identified as a community acquired infection. ...

By Cochrane & Associates, LLC

On April 29, 2020, the U.S. District Court for the District of Utah issued a temporary restraining order (TRO) to halt the sale of a fraudulent coronavirus (COVID-19) treatment. The U.S. Department of Justice (DOJ) announced the court’s decision in an effort to halt the sale of silver products fraudulently claimed to prevent and cure COVID-19. DOJ filed a civil complaint on April 27, ...

By Bergeson & Campbell, P.C.

THOUSAND OAKS, Calif., May 12, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Otezla® (apremilast) have partnered with pop icon and entrepreneur Lance Bass, for the Double Take campaign to empower people to take action when it comes to psoriatic arthritis. As a singer, dancer and entertainer, Bass understands the importance of staying in tune with your body. Through the campaign, he has created ...

By Amgen Inc.

The new Vitassay SARS-CoV-2 + Flu A + B + RSV + Adeno Resp. is a rapid, immunochromatographic assay for the simultaneous qualitative detection of nucleoprotein antigen of SARS-CoV-2, Influenza type A, Influenza type B, RSV and Adenovirus from nasopharyngeal swabs samples from patients suspected of COVID-19 infection and/or Influenza A and/or Influenza B and/or Respiratory Syncytial Virus (RSV) ...

By Vitassay Healthcare, S.L.U.

Lumen Bioscience, a clinical-stage biotechnology company developing biologic drugs for highly prevalent diseases, today announced several funding milestones supporting the development of its therapeutics to prevent serious diarrheal diseases. The first is a $5 million grant from the Bill & Melinda Gates Foundation for a second Phase 2 study of an improved anti-campylobacter therapeutic, ...

By Lumen Bioscience, Inc.

The U.S. Environmental Protection Agency (EPA) is warning the public about a potential threat from an illegal pesticide product uncovered during an inspection of a shipment at a warehouse in Kearny, NJ. EPA discovered that a Brooklyn-based company had attempted to import mothballs from China that could be mistaken for candy and are not registered with EPA, as required by federal law. These ...

By US EPA - Environmental Protection Agency

When buildings stand virtually abandoned due to pandemic stay-at-home orders, water stops flowing through their plumbing and bad things start to happen inside the pipes. Harmful chemicals begin to build up and potentially pathogenic microorganisms start to grow. It takes only days for dangerous concentrations to form, but many buildings will remain closed for months. How serious might the problem ...

By Fluence Corporation

Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases, today announced a research collaboration with a top-three animal health company to develop orally delivered biologic drugs to reduce the use of antibiotics in animal husbandry. The collaboration’s initial focus is on development of therapeutic proteins against ...

By Lumen Bioscience, Inc.

This year, the largest Ebola epidemic in history occurred in multiple countries across West Africa. In September, a person who traveled from Africa to the United States was diagnosed with the condition in Texas. The virus then spread to several healthcare workers who provided the patient with medical care. Others who offered medical care in West Africa have also become infected and have been ...

By Cochrane & Associates, LLC

Lumen Bioscience—a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases—today announced the receipt of a $3.6 million award from the Department of Defense (DoD) for advanced biomedical product development in support of Naval operations. The award from the Medical Technology Consortium (MTEC), a 501(c)(3) biomedical technology consortium ...

By Lumen Bioscience, Inc.

Today, the International Zinc Association (IZA) announces new commitments to fund UNICEF programmes in Brazil against zinc deficiency, a public health threat that contributes to the deaths of more than 450,000 children each year. At the beginning of 2011 IZA and UNICEF will identify an additional programme in the African continent, where zinc deficiency is also affecting children. IZA support ...

By CSRwire - Corporate Social Responsibility Newswire

Due to a significant increase in adverse incidents, the U.S. Environmental Protection Agency is taking a series of actions to increase the safety of spot-on pesticide products for flea and tick control for cats and dogs. Immediately, EPA will begin reviewing labels to determine which ones need stronger and clearer labeling statements. Next, EPA will develop more stringent testing and evaluation ...

By US EPA - Environmental Protection Agency

Symberix, a leader in the discovery of drugs that selectively target the human microbiome, announced today that it has been awarded two Small Business Innovation Research (SBIR) grants from the National Institutes of Health (NIH). These grants will fund the research of new drugs that safely and selectively inhibit a bacterial enzyme responsible for a number of dose-limiting gastrointestinal (GI) ...

By Symberix, Inc.

Eligo Bioscience SA, a Paris, France-based microbiome engineering company, today announced that the Company presented preclinical data on its lead drug candidate, EB003, for the treatment of severe diarrhea induced by shiga-toxin (Stx) producing E. coli (STEC, leading to Hemolytic Uremic Syndrome), at the 14th Annual CRISPR 2021 meeting held June 1-10, 2021. The data presented further supports ...

By Eligo Bioscience

PRINCETON, N.J., June 3, 2022 – Taiho Oncology, Inc. announced today updated results of the Phase 2 FOENIX-CCA2 trial of futibatinib, confirming results observed in an earlier analysis. The trial was conducted in patients with locally advanced or metastatic unresectable intrahepatic (inside the liver) cholangiocarcinoma (iCCA) harboringFGFR2 gene rearrangements including fusions. These data ...

By Taiho Oncology, Inc.